References
- Mendelsohn M, Karas R. Molecular and cellular basis of cardiovascular gender differences. Science 2005;308:1583–6
- Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991;265:1861–7
- Mendelsohn M, Karas R. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801–11
- Knowlton AA, Lee AR. Estrogen and the cardiovascular system. Pharmacol Ther 2012;135:54–70
- Shinmura K, Nagai M, Tamaki K, Bolli R. Loss of ischaemic preconditioning in ovariectomized rat hearts: possible involvement of impaired protein kinase C epsilon phosphorylation. Cardiovasc Res 2008;79:387–94
- Arias-Loza PA, Kreissl MC, Kneitz S, et al. The estrogen receptor-α is required and sufficient to maintain physiological glucose uptake in the mouse heart. Hypertension 2012;60:1070–7
- Brar BK, Jonassen AK, Stephanou A, et al. UCN protects against ischemic and reperfusion injury via a MAPK-dependent pathway. J Biol Chem 2000;275:8508–14
- Brar BK, Stephanou A, Knight R, Latchman DS. Activation of protein kinase B/Akt by UCN is essential for its ability to protect cardiomyocytess against hypoxia/reoxygenation-induced cell death. J Mol Cell Cardiol 2002;34:483–92
- Smani T, Calderón-Sanchez E, Gómez-Hurtado N, et al. Mechanisms underlying the activation of L-type calcium channels by urocortin in rat ventricular myocytes. Cardiovasc Res 2010;87:459–66
- Takahashi K. Distribution of urocortins and corticotropin-releasing factor receptors in the cardiovascular system. Int J Endocrinol 2012;2012:395284
- Emeto TI, Moxon JV, Rush C, et al. Relevance of urocortins to cardiovascular disease. J Mol Cell Cardiol 2011;51:299–307
- Cong B, Zhu X, Cao B, et al. Estrogens protect myocardium against ischemia/reperfusion insult by up-regulation of CRH receptor type 2 in female rats. Int J Cardiol 2013;168:4755–60
- Cong B, Xu Y, Sheng H, et al. Cardioprotection of 17β-estradiol against hypoxia/reoxygenation in cardiomyocytes is partly through up-regulation of CRH receptor type 2. Mol Cell Endocrinol 2014;382:17–25
- Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II). JAMA 2002;288:49–57
- Hodis HN, Mack WJ, Azen SP, et al. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med 2003;349:535–45
- Harman SM. Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum. Fertil Steril 2014;101:887–97
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 2002;288:321–33
- Brook RD, Appel LJ, Rubenfire M, et al. Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the American Heart Association. Hypertension 2013;61:1360–83
- Pighon A, Gutkowska J, Jankowski M, et al. Exercise training in ovariectomized rats stimulates estrogenic-like effects on expression of genes involved in lipid accumulation and subclinical inflammation in liver. Metabolism 2011;60:629–39
- Hao L, Wang Y, Duan Y, Bu S. Effects of treadmill exercise training on liver fat accumulation and estrogen receptor alpha expression in intact and ovariectomized rats with or without estrogen replacement treatment. Eur J Appl Physiol 2010;109:879–86
- Souza SB, Flues K, Paulini J, et al. Role of exercise training in cardiovascular autonomic dysfunction and mortality in diabetic ovariectomized rats. Hypertension 2007;50:786–91
- Li L, Chen X, Lv S, et al. Influence of exercise on bone remodeling-related hormones and cytokines in ovariectomized rats: a model of postmenopausal osteoporosis. PLoS One 2014;9:e112845
- Haines CD, Harvey PA, Leinwand LA. Estrogens mediate cardiac hypertrophy in a stimulus-dependent manner. Endocrinology 2012;153:4480–90
- Murphy E. Estrogen signaling and cardiovascular disease. Circ Res 2011;109:687–96
- Knight RA, Chen-Scarabelli C, Yuan Z, et al. Cardiac release of UCN precedes the occurrence of irreversible myocardial damage in the rat heart exposed to I/R injury. FEBS Lett 2008;582:984–90
- Coste SC, Heldwein KA, Stevens SL, et al. IL-1alpha and TNFalpha down-regulate CRH receptor-2 mRNA expression in the mouse heart. Endocrinology 2001;142:3537–45